BioCentury
ARTICLE | Company News

Geron, Transgenomic deal

June 9, 2003 7:00 AM UTC

The companies expanded an existing deal under which TBIO received a non-exclusive license to GERN's patents covering the manufacture of phosphoramidate-based oligonucleotides for research purposes. As...